Mono Pharmacare Limited (NSE:MONOPHARMA)
India · Delayed Price · Currency is INR 17.05
0.00 (0.00%)
Dec 16, 2025, 1:25 PM IST
Mono Pharmacare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
Operating Revenue | 1,475 | 1,683 | 1,223 | 330.87 | 369.83 | 282.66 | Upgrade |
Other Revenue | 0.89 | 0.89 | 0.25 | 0.57 | 1.1 | 1.12 | Upgrade |
| 1,476 | 1,684 | 1,224 | 331.44 | 370.93 | 283.78 | Upgrade | |
Revenue Growth (YoY) | 3.14% | 37.65% | 269.19% | -10.65% | 30.71% | 142.81% | Upgrade |
Cost of Revenue | 1,348 | 1,524 | 1,107 | 292.42 | 347.3 | 265.87 | Upgrade |
Gross Profit | 127.7 | 160.72 | 116.75 | 39.02 | 23.63 | 17.91 | Upgrade |
Selling, General & Admin | 49.37 | 45.96 | 40.66 | 10.34 | 7.44 | 7.19 | Upgrade |
Other Operating Expenses | 29.95 | 36.73 | 12.11 | 5.7 | 2.28 | 1.13 | Upgrade |
Operating Expenses | 80.54 | 83.97 | 53.91 | 16.55 | 10.8 | 9.61 | Upgrade |
Operating Income | 47.16 | 76.76 | 62.83 | 22.48 | 12.84 | 8.31 | Upgrade |
Interest Expense | -35.96 | -35.53 | -28.47 | -8.46 | -6.55 | -6.45 | Upgrade |
Interest & Investment Income | 8.13 | 8.13 | 0.26 | 0.03 | 0.09 | - | Upgrade |
Other Non Operating Income (Expenses) | -5.01 | -4.72 | -2.36 | -0.86 | -0.87 | -0.17 | Upgrade |
Pretax Income | 14.32 | 44.63 | 32.26 | 13.18 | 5.51 | 1.69 | Upgrade |
Income Tax Expense | 5.89 | 13.57 | 7.67 | 3.73 | 2 | 0.74 | Upgrade |
Earnings From Continuing Operations | 8.43 | 31.06 | 24.59 | 9.45 | 3.51 | 0.95 | Upgrade |
Minority Interest in Earnings | -0.1 | -0.16 | -0.17 | -0.02 | - | - | Upgrade |
Net Income | 8.33 | 30.9 | 24.42 | 9.44 | 3.51 | 0.95 | Upgrade |
Net Income to Common | 8.33 | 30.9 | 24.42 | 9.44 | 3.51 | 0.95 | Upgrade |
Net Income Growth | -70.96% | 26.52% | 158.84% | 168.91% | 268.98% | 377.89% | Upgrade |
Shares Outstanding (Basic) | 19 | 18 | 15 | 6 | 5 | 5 | Upgrade |
Shares Outstanding (Diluted) | 19 | 18 | 15 | 6 | 5 | 5 | Upgrade |
Shares Change (YoY) | 7.91% | 15.09% | 171.01% | 15.18% | - | - | Upgrade |
EPS (Basic) | 0.43 | 1.75 | 1.59 | 1.67 | 0.71 | 0.19 | Upgrade |
EPS (Diluted) | 0.43 | 1.75 | 1.59 | 1.67 | 0.71 | 0.19 | Upgrade |
EPS Growth | -73.09% | 10.00% | -4.55% | 134.45% | 274.94% | 400.00% | Upgrade |
Free Cash Flow | 5.87 | -45.29 | -89.47 | -401.73 | 2.26 | -8.47 | Upgrade |
Free Cash Flow Per Share | 0.31 | -2.56 | -5.83 | -70.92 | 0.46 | -1.72 | Upgrade |
Gross Margin | 8.65% | 9.54% | 9.54% | 11.77% | 6.37% | 6.31% | Upgrade |
Operating Margin | 3.20% | 4.56% | 5.13% | 6.78% | 3.46% | 2.93% | Upgrade |
Profit Margin | 0.56% | 1.84% | 2.00% | 2.85% | 0.95% | 0.34% | Upgrade |
Free Cash Flow Margin | 0.40% | -2.69% | -7.31% | -121.21% | 0.61% | -2.99% | Upgrade |
EBITDA | 48.39 | 78.04 | 63.98 | 22.98 | 13.92 | 9.59 | Upgrade |
EBITDA Margin | 3.28% | 4.63% | 5.23% | 6.93% | 3.75% | 3.38% | Upgrade |
D&A For EBITDA | 1.22 | 1.29 | 1.15 | 0.51 | 1.08 | 1.28 | Upgrade |
EBIT | 47.16 | 76.76 | 62.83 | 22.48 | 12.84 | 8.31 | Upgrade |
EBIT Margin | 3.20% | 4.56% | 5.13% | 6.78% | 3.46% | 2.93% | Upgrade |
Effective Tax Rate | 41.14% | 30.41% | 23.78% | 28.27% | 36.30% | 43.76% | Upgrade |
Revenue as Reported | 1,484 | 1,693 | 1,224 | 331.48 | 371.03 | 283.78 | Upgrade |
Advertising Expenses | - | 6.49 | 4.31 | 1.21 | 0.32 | 1.24 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.